Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Patient with relapsing remitting multiple sclerosis taking avonex are included in this double
blind randomized control trial. Simvastatin is compared to placebo. end points of edss ,
total attack, new enhancing lesion and newt2 lesion in mri is evaluated as end point.